Veracyte, Inc.

VCYT
Real-time BATS EXCHANGE - 01/21 04:58:16 pm
28.495USD
-5.97%
Prev.30.1500
Open29.9500
High30.1500
Low28.3250
Volume416 083
Financials
Sales 2019 120 M
EBIT 2019 -11,2 M
Net income 2019 -9,07 M
Finance 2019 197 M
Yield 2019 -
P/E ratio 2019 -142x
P/E ratio 2020 -133x
EV / Sales2019 9,90x
EV / Sales2020 8,67x
Capitalization 1 388 M
Company
Veracyte, Inc. is a genomic diagnostics company. The Company, through its scientific platform, which utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, produces genomic tests. It provides various genomic tests, including Afirma Genomic Sequencing...
Sector :
Bio Diagnostics & Testing
Calendar :
2020-03-25 Earnings Release
Trading Rating :
Investor Rating :
Latest news
01/08VERACYTE : Announces Biopharmaceutical Collaboration with Acerta Pharma
BU
2019VERACYTE, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
2019VERACYTE : Acquires Exclusive License to NanoString Diagnostics Platform, Positioning Veracyte To Expand Its Genomic Testing Business Globally
BU
2019VERACYTE : Announces New Data That Advance Understanding of Genomic Alterations Targeted by Precision Medicine Therapies for Thyroid Cancer
BU
2019VERACYTE : Announces New Data Characterizing Genomic Alterations in Thyroid Cancer To Be Presented at 89th Annual Meeting of the American Thyroid Association
BU
2019VERACYTE : 3Q Earnings Snapshot
AQ
2019VERACYTE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
2019VERACYTE, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance30,230,230,2
Spread/Res.-5,8%-5,8%-5,8%
Spread/Supp.0,14%9,4%15%
Support28,426,024,7